Agapi Ioannidou
Overview
Explore the profile of Agapi Ioannidou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manola K, Zachaki S, Kakosaiou K, Ioannidou A, Kalomoiraki M, Rampias T
Life (Basel)
. 2024 Oct;
14(10).
PMID: 39459611
Background: Aberrant gene promoter methylation is one of the hallmarks of Acute Myeloid Leukemia (AML). is an important gene, implicated in sister chromatids cohesion, DNA repair, the regulation of gene...
2.
Ioannidou A, Zachaki S, Daraki A, Margariti I, Pantelia D, Diamantopoulou P, et al.
Anticancer Res
. 2019 Jun;
39(6):2861-2869.
PMID: 31177124
Background/aim: PON1 gene has an executive role in antioxidant defense, protecting cells from genotoxic factors. Q192R and L55M PON1 polymorphisms reduce catalytic activity of the encoded protein. These polymorphisms were...
3.
Ioannidou A, Zachaki S, Karakosta M, Daraki A, Roussou P, Manola K
Cytogenet Genome Res
. 2018 Mar;
154(3):126-131.
PMID: 29587287
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults and is characterized by the presence of specific cytogenetic abnormalities. CLL research has been focused on epigenetic...
4.
Kakosaiou K, Panitsas F, Daraki A, Pagoni M, Apostolou P, Ioannidou A, et al.
Leuk Lymphoma
. 2018 Feb;
59(10):2439-2446.
PMID: 29411666
Mutations of ASXL1 are early events in acute myeloid leukemia (AML) leukemogenesis and have been associated with unfavorable prognosis. In this study, we investigated the type and frequency of ASXL1...